AtriCure ablation clamp
This article was originally published in The Gray Sheet
AtriCure's Isolator bipolar ablation clamp is FDA cleared for ablation of cardiac tissue, the firm announces July 9. The device previously was cleared for general soft tissue ablation. Isolator's parallel stainless steel jaws deliver radiofrequency energy to create lesions during surgical ablation procedures to block abnormal electrical signals. AtriCure is pursuing a more specific atrial fibrillation indication...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.